Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008085 |
---|---|
Receipt number | R000009512 |
Scientific Title | A Phase II study of Neoadjuvant chemotherapy in Tri-weekly nab-Paclitaxel followed by FEC with Operable HER2 Negative breast cancer |
Date of disclosure of the study information | 2012/06/01 |
Last modified on | 2019/03/22 16:15:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/06/01 23:34:28 | ||
2 | Update | 2012/06/02 13:07:49 | Public title |
|
3 | Update | 2012/06/02 13:30:19 | Public title |
|
4 | Update | 2012/06/08 17:52:43 | Last name of contact person Last name of contact person |
|
5 | Update | 2012/06/08 17:55:07 | Interventions/Control_1 |
|
6 | Update | 2012/10/02 20:35:57 | Public title |
|
7 | Update | 2012/10/02 20:44:15 | Last name of contact person Last name of contact person Address Address TEL Organization Organization Category of Funding Organization |
|
8 | Update | 2013/12/05 22:07:13 | Recruitment status Last follow-up date |
|
9 | Update | 2014/06/01 12:48:28 | TEL |
|
10 | Update | 2019/03/22 16:15:12 | Recruitment status Date of IRB Last follow-up date |